Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease.
Toft M, Mata IF, Ross OA, Kachergus J, Hulihan MM, Haugarvoll K, Stone JT, Blazquez M, Gibson JM, Aasly JO, White LR, Lynch T, Adler CH, Gwinn-Hardy K, Farrer MJ. Toft M, et al. Among authors: haugarvoll k. Mov Disord. 2007 Feb 15;22(3):389-92. doi: 10.1002/mds.21217. Mov Disord. 2007. PMID: 17216639
ELAVL4, PARK10, and the Celts.
Haugarvoll K, Toft M, Ross OA, Stone JT, Heckman MG, White LR, Lynch T, Gibson JM, Wszolek ZK, Uitti RJ, Aasly JO, Farrer MJ. Haugarvoll K, et al. Mov Disord. 2007 Mar 15;22(4):585-7. doi: 10.1002/mds.21336. Mov Disord. 2007. PMID: 17230446
FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.
Wider C, Dachsel JC, Soto AI, Heckman MG, Diehl NN, Yue M, Lincoln S, Aasly JO, Haugarvoll K, Trojanowski JQ, Papapetropoulos S, Mash D, Rajput A, Rajput AH, Gibson JM, Lynch T, Dickson DW, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. Wider C, et al. Among authors: haugarvoll k. Mov Disord. 2009 Feb 15;24(3):455-9. doi: 10.1002/mds.22442. Mov Disord. 2009. PMID: 19133659 Free PMC article.
Reported mutations in GIGYF2 are not a common cause of Parkinson's disease.
Vilariño-Güell C, Ross OA, Soto AI, Farrer MJ, Haugarvoll K, Aasly JO, Uitti RJ, Wszolek ZK. Vilariño-Güell C, et al. Among authors: haugarvoll k. Mov Disord. 2009 Mar 15;24(4):619-20. doi: 10.1002/mds.22451. Mov Disord. 2009. PMID: 19133664 No abstract available.
Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease.
Aasly JO, Vilariño-Güell C, Dachsel JC, Webber PJ, West AB, Haugarvoll K, Johansen KK, Toft M, Nutt JG, Payami H, Kachergus JM, Lincoln SJ, Felic A, Wider C, Soto-Ortolaza AI, Cobb SA, White LR, Ross OA, Farrer MJ. Aasly JO, et al. Among authors: haugarvoll k. Mov Disord. 2010 Oct 15;25(13):2156-63. doi: 10.1002/mds.23265. Mov Disord. 2010. PMID: 20669305 Free PMC article.
Treatment in early Parkinson's disease: the Norwegian ParkWest study.
Tveiten OV, Skeie GO, Haugarvoll K, Müller B, Larsen JP, Tysnes OB. Tveiten OV, et al. Among authors: haugarvoll k. Acta Neurol Scand. 2013 Aug;128(2):107-13. doi: 10.1111/ane.12055. Epub 2012 Nov 29. Acta Neurol Scand. 2013. PMID: 23190324
59 results